The Future Evidence Foundation aspires to dramatically improve lives by changing the way the world creates and uses trustworthy knowledge.
In 2014, we launched Covidence - a SAAS platform that enables research teams in any sector to easily, quickly and systematically synthesise the world's mountains of primary research and uncover actionable insights.
Over this time, we have also worked with others to develop the Living Evidence approach to systematic review. Conventional systematic reviews are static, one-off summaries of the science. But because science doesn't stand still, these summaries quickly go out of date and lose their utility. We collaborate with colleagues from across the evidence ecosystem to develop a new approach in which systematic reviews are regularly updated to reflect the latest scientific knowledge.
Role context
The Future Evidence Foundation has been engaged to provide technical and operational support to the World Health Organization to redesign and implement updated normative guidelines systems and processes under the Guidance 2.0 initiative.
These global guidelines are used as the basis for public health policy and clinical decision-making across countries and within global health partners who drive procurement of essential medicine and products. This normative function is central to the organization's mission and has been prioritized in its current strategic plan as a critical enabler of impact at country level. Simply put, these guidelines are essential for moving health research and evidence into practice and can determine the standard of care and treatment someone receives, and their access to diagnostics, medicine, and health products.
Current guideline development processes utilize traditional global best practice methods to ensure scientific rigor and transparency. However, decisions about which guidelines are developed and when have traditionally been undertaken within individual technical teams, and without cross-org coordination or prioritization to ensure the maximal impact of norms and standards at country-level. In addition, guidelines routinely take years to develop and are often updated only on pre-specified schedules and thus can be slow to respond to new evidence that may lead to important changes in global policy or practice. Adopting innovative, tech-enabled living guideline methodologies drives engagement with and adoption of new evidence.
The Guidance 2.0 redesign process is one of the highest organizational priorities and is supported by major philanthropic foundations, including the Gates Foundation, The Wellcome Trust, and the Novo Nordisk Foundation.
About the role
This is a fixed term, full time role until December 2028.
This role will provide overall analytical and technical support for the Guidance 2.0 project, flexibly partnering with project leadership, technical teams, and collaborating institutions to assess the current state, make data-driven recommendations for system improvement, and support implementation of new systems and processes. The analyst will design and manage frameworks for capturing insights, sharing knowledge, building capacity and incorporating feedback such that new processes are not only implemented, but understood, adopted, adapted and continuously improved.
This role will enable all stakeholders involved in the project, including partner organizations and funders, to learn by doing and strengthen organizational capabilities.
This role is an assignment to the World Health Organization (WHO), working closely with WHO technical teams and leadership.
Please note: Candidates must be able to travel freely to Geneva several times a year.